Your browser doesn't support javascript.
loading
Ventricular assist device support following pediatric heart transplantation.
Krauss, Annemarie; Pidborochynski, Tara; Buchholz, Holger; Urschel, Simon; Al-Akalabi, Mohammed; Freed, Darren H; Anand, Vijay; Holinkski, Paula; Bates, Angela; Conway, Jennifer.
Afiliação
  • Krauss A; Division of Pediatric Cardiology at the University of Alberta, Edmonton, Alberta, Canada.
  • Pidborochynski T; Division of Pediatric Cardiology at the University of Alberta, Edmonton, Alberta, Canada.
  • Buchholz H; Division of Cardiac Surgery, University of Alberta, Edmonton, Alberta, Canada.
  • Urschel S; Division of Pediatric Cardiology at the University of Alberta, Edmonton, Alberta, Canada.
  • Al-Akalabi M; Division of Cardiac Surgery, University of Alberta, Edmonton, Alberta, Canada.
  • Freed DH; Division of Pediatric Cardiac Surgery, Stollery Children's Hospital, Edmonton, Alberta, Canada.
  • Anand V; Division of Cardiac Surgery, University of Alberta, Edmonton, Alberta, Canada.
  • Holinkski P; Division of Pediatric Cardiac Surgery, Stollery Children's Hospital, Edmonton, Alberta, Canada.
  • Bates A; Pediatric Critical Care, University of Alberta, Edmonton, Alberta, Canada.
  • Conway J; Pediatric Critical Care, University of Alberta, Edmonton, Alberta, Canada.
Pediatr Transplant ; 26(8): e14363, 2022 12.
Article em En | MEDLINE | ID: mdl-35841596
ABSTRACT

BACKGROUND:

VAD support for early graft failure after HTx is a rare event in pediatrics.

METHODS:

We retrospectively describe our single-center experience with post-HTx VAD support in a cohort of patients transplanted between 01/05 and 12/20.

RESULTS:

Nine patients underwent VAD insertion in the early post-HTx period [median age 6.1 years (Range 0.3-20.3), median weight 17.6 kg (Range 3.5-65.0), and congenital heart disease (67%)]. Of the nine patients with early graft failure, almost half (44%) were implanted after 2015 and all of these patients had a pre-HTx plan for possible post-transplant VAD insertion. Time to VAD implant was a median of 0 day (Range 0-11). Total time on VAD support was a median of 12 days (Range 3.0-478.0). Two-thirds (n = 6; 67%) of the patients were weaned from support, retransplanted (11%) and two patients died (22%). In all of the patients where post-HTx VAD was anticipated there was 100% survival.

CONCLUSIONS:

In this small patient series, post-HTx VAD was a useful measure in selected patients especially with pre-HTx planning. However, more shared experiences to verify these findings are needed.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pediatria / Coração Auxiliar / Transplante de Coração / Insuficiência Cardíaca Tipo de estudo: Observational_studies Limite: Adolescent / Adult / Child / Child, preschool / Humans / Infant Idioma: En Revista: Pediatr Transplant Assunto da revista: PEDIATRIA / TRANSPLANTE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pediatria / Coração Auxiliar / Transplante de Coração / Insuficiência Cardíaca Tipo de estudo: Observational_studies Limite: Adolescent / Adult / Child / Child, preschool / Humans / Infant Idioma: En Revista: Pediatr Transplant Assunto da revista: PEDIATRIA / TRANSPLANTE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá